NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Pharmstandard

Pharmstandard

Overview

Pharmstandard develops, manufactures, and distributes a range of pharmaceutical products, including prescription and over-the-counter drugs . They offer contract manufacturing services and their product portfolio includes drugs for the treatment of cardiovascular, gastroenterology, cancer, neurology, diabetes, and infectious diseases .

Year Founded

2003

Portfolio Companies

2

Investments

Pharmstandard investments
CompanyDateStageLead
GenotekDec 2016VC RoundLead
BIOCADJul 2014Buyout/LBOLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersMoscow
Year Founded2003

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.